AstraZeneca PLC (AZN) operating KPIs
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca net cash inflow from operating activities ($M) ($M)
Form 20-F & Form 6-K Consolidated Statement of Cash Flows (Postgres DB)
Latest, Q2 2026
2,865
Period ended Jun 30, 2026
Change on a year earlier
-15.4%
3,386 in Q2 2025
History
22 quarters
Since Q1 2021
Sources
22
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up net cash inflow from operating activities ($m)
- Share-based payment charge in operating cash flow ($M)–
- Change in inventories in operating cash flow ($M)–
- Tax paid ($M)-1,525 · Q2 2026
- Net cash outflow from investing activities ($M)–
- Purchase of property, plant and equipment ($M)-763 · Q2 2026
- Disposal of property, plant and equipment ($M)–
- Net cash outflow from financing activities ($M)–
- Issue of loans and borrowings ($M)–
- Repayment of loans and borrowings ($M)–
- Dividends paid ($M)-1 · Q2 2026
- Issue of Ordinary Shares ($M)–
- Purchase of shares by Employee Benefit Trust ($M)–
- Effects of foreign exchange rate changes on cash ($M)–
Cite this data
StockData. (2026). AstraZeneca Net cash inflow from operating activities ($M) ($M), quarterly Q1 2021–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/fin_ocf
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.